Yes but we have only just started to ratchet up sales in other geographies with a lot more to come.
Barda trial finishing soon will add big time to US sales.
And meanwhile the R&D department is growing
Ann: FY24 Trading Result (unaudited), page-38
-
- There are more pages in this discussion • 152 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.68 |
Change
0.065(2.49%) |
Mkt cap ! $1.849B | |||
| Open | High | Low | Value | Volume |
| $2.69 | $2.74 | $2.63 | $2.940M | 1.096M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 4120 | $2.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.68 | 13850 | 11 |
View Market Depth
| Last trade - 11.57am 26/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |